Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06321601 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
A Phase 3 study of Vasculitis, sponsored by Amgen.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
- 20
- Study locations
NCT06321601 is a Phase 3 study of Vasculitis that is actively recruiting participants, run by Amgen. The registered enrollment target is 20 participants, below the 27,317-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The trial reports 20 study locations across 11 states.
The verdict
NCT06321601, a Phase 3 study of Vasculitis, is actively recruiting participants, sponsored by Amgen.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
- 20
- Study locations
Study Summary
The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV.
Conditions Studied
Interventions
- DRUG Avacopan
Study Locations (20)
Other
- Universitair Ziekenhuis Gent - Ghent
- Universitair Ziekenhuis Leuven - Gasthuisberg - Leuven
- Vseobecna fakultni nemocnice v Praze - Prague
- Fakultni nemocnice v Motole - Prague
- Centre Hospitalier Universitaire de Bordeaux - Hopital Pellegrin - Bordeaux
- Hospices Civils de Lyon Hopital Femme Mere Enfant - Bron
- Hopital Necker Enfants Malades - Paris
North Carolina
- University of North Carolina - Chapel Hill
- Wake Forest University Health Sciences - Charlotte
Ohio
- Akron Childrens Hospital - Akron
- Cleveland Clinic Foundation - Cleveland
Alberta
- Alberta Childrens Hospital - Calgary
- Stollery Childrens Hospital - Edmonton
Georgia
- Emory University - Atlanta
Indiana
- Riley Hospital for Children - Indianapolis
Minnesota
- University of Minnesota Masonic Childrens Hospital Discovery Clinic - Minneapolis
New York
- Cohen Children Medical Center - Lake Success
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-10-22 |
| Est. Completion | 2028-09-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06321601
The ClinicalTrials.gov registry entry for NCT06321601 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 27,317-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vasculitis appearing as the primary indexed condition, and to 1 intervention - of which Avacopan is the first listed.
NCT06321601 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Other, North Carolina, Ohio.
Frequently Asked Questions
What is clinical trial NCT06321601 about?
NCT06321601 is a clinical study titled "Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.". The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV.
What is the current status of trial NCT06321601?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2024-10-22. Estimated completion is 2028-09-26.
What conditions does trial NCT06321601 study?
This clinical trial studies the following conditions: Vasculitis.
What interventions are being tested in trial NCT06321601?
The interventions under investigation include: Avacopan (DRUG).
Who is sponsoring clinical trial NCT06321601?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06321601 being conducted?
This trial has 20 study locations across Georgia, Indiana, Minnesota, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vasculitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
ACTIVE NOT RECRUITING · Phase 3
-
Longitudinal Study for Relapsing Polychondritis
RECRUITING
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
RECRUITING
-
Vasculitis Pregnancy Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.